688319.SH
欧林生物
SSE · Healthcare · Biotechnology · CN
CNY 27.82
−7.42%Margins
Gross margin
92.7%
EBITDA margin
9.0%
EBIT margin
9.1%
Net margin
7.3%
FCF margin
0.0%
6.1%
Return on equity
2.8%
Return on assets
5.6%
Return on invested capital
0.38x
Asset turnover
CNY 103.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026